These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8730395)

  • 21. Hypertension and related risk factors in type 2 diabetes mellitus.
    Lunetta M; Barbagallo A; Crimi S; Di Mauro M; Sangiorgio L; Mughini L
    Minerva Endocrinol; 1999 Jun; 24(2):45-50. PubMed ID: 10941422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Metabolic syndrome with vascular risk and arterial hypertension].
    Wassermann AO; Grosso CP
    Medicina (B Aires); 1996; 56(2):183-94. PubMed ID: 8935572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin resistance and upper-normal glucose levels in hypertension: a review.
    Cubeddu LX; Hoffmann IS
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S52-5. PubMed ID: 11986895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance and hypertension--implications for treatment.
    Rutherford PA; Thomas TH; Wilkinson R
    Postgrad Med J; 1991 Oct; 67(792):869-75. PubMed ID: 1758796
    [No Abstract]   [Full Text] [Related]  

  • 25. [Insulin resistance and hypertension].
    Herrera Acosta J
    Gac Med Mex; 1994; 130(3):126-7. PubMed ID: 7657073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Arterial hypertension, hyperinsulinism and insulin resistance].
    Ribstein J; DuCailar G; Mimran A
    Presse Med; 1992 Sep; 21(28):1318-23. PubMed ID: 1438100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.
    Hernández-Mijares A; Jarabo-Bueno MM; López-Ruiz A; Solá-Izquierdo E; Morillas-Ariño C; Martínez-Triguero ML
    Int J Obes (Lond); 2007 Jun; 31(6):927-32. PubMed ID: 17264851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New paradigm for the mechanism and treatment of insulin resistance.
    Lautt WW
    Proc West Pharmacol Soc; 2002; 45():223-4. PubMed ID: 12434584
    [No Abstract]   [Full Text] [Related]  

  • 29. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
    Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Obesity and hypertension].
    Miura J; Ikeda Y
    Nihon Rinsho; 1992 May; 50 Suppl():415-9. PubMed ID: 1512979
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Disorders of glucose metabolism and hypertension--common etio-pathogenetic factors?].
    Ryczak E; Hanzlik J
    Kardiol Pol; 1992; 36(2):115-8. PubMed ID: 1583827
    [No Abstract]   [Full Text] [Related]  

  • 33. [Arterial hypertension, insulin resistance, and disorders of membrane permeability].
    Clara JG
    Rev Port Cardiol; 1991 Sep; 10(9):687-91. PubMed ID: 1747260
    [No Abstract]   [Full Text] [Related]  

  • 34. [Obesity-related hypertension].
    Ueda Y; Aoi W
    Ryoikibetsu Shokogun Shirizu; 1996; (12):163-6. PubMed ID: 9047433
    [No Abstract]   [Full Text] [Related]  

  • 35. The insulin resistance syndrome.
    Smolar EN
    Compr Ther; 1997 Apr; 23(4):237-43. PubMed ID: 9167914
    [No Abstract]   [Full Text] [Related]  

  • 36. Relationship of adiposity to subclinical atherosclerosis in obese patients with type 2 diabetes.
    Hegazi RA; Sutton-Tyrrell K; Evans RW; Kuller LH; Belle S; Yamamoto M; Edmundowicz D; Kelley DE
    Obes Res; 2003 Dec; 11(12):1597-605. PubMed ID: 14694226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The value of certain parameters in the diagnosis and detection of metabolic X syndrome].
    Suba I; Halmos T; Kautzky L
    Orv Hetil; 1997 Sep; 138(38):2407-11. PubMed ID: 9380379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prediction of the development of hypertension].
    Maebuchi D; Kiyohara Y; Iida M
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():96-9. PubMed ID: 16981526
    [No Abstract]   [Full Text] [Related]  

  • 39. [How I investigate...the insulin resistance syndrome using biological markers].
    Luyckx F; Scheen AJ; Gielen J; Lefèbvre PJ
    Rev Med Liege; 1997 Oct; 52(10):686-91. PubMed ID: 9446171
    [No Abstract]   [Full Text] [Related]  

  • 40. Obesity hypertension, salt sensitivity and insulin resistance.
    Rocchini AP
    Nutr Metab Cardiovasc Dis; 2000 Oct; 10(5):287-94. PubMed ID: 11213538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.